In our view, FMC is at risk for a dividend cut. Should FMC not see profit growth in 2025 and 2026 as expected, the dividend may be reduced or cut alltogether. FMC pays a little less than $300 million ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzdTM, signi ...

Tesla, Inc.'s stock is highly speculative with ambitious projects like Robotaxis, but recent financials fell short. Read more ...

Hangover Relief: Participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment, and reduced headache compared to ...

Vanda expects to immediately begin preparing BLA and MAA applications for the U.S. and EU.

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Musk announced that unsupervised Full Self Driving (FSD) would launch as a paid service in Austin by June 2025, with plans to expand across the U.S. This includes Tesla's internal fleet already ...

Supervisory Board Freya Pharma Solutions Freya Pharma’s new Supervisory Board From left to right: Manuel Voll, James E.

Lawyers at Miller Thomson, Bennett Jones, BLG, Dickinson Wright, Pallett Valo, Stikeman Elliott, Thornton Grout Finnigan, ...